Daily BriefsThematic (Sector/Industry)

Daily Brief Thematic (Sector/Industry): Charted Insights: Understanding the Impact of the US Reciprocal Tariff Plan: A Data-Backed Breakdown and more

In today’s briefing:

  • Charted Insights: Understanding the Impact of the US Reciprocal Tariff Plan: A Data-Backed Breakdown
  • Decoding Trump’s Reciprocal Tariffs: Limited Shock for India, Sector Rotation Ahead
  • Ohayo Japan | Tariffs On, Risk Off
  • Junior Copper Miners: An Update After 1Q25
  • No Tariffs on Semiconductors – but Does It Matter?
  • Japan Morning Connection: Rough Start with US Meltdown but Trump Showing Willingness to Negotiate
  • Hardman & Co Insight: 2024 Pharma Statistics
  • South African Listed Property Review – March 2025
  • US EV Charging Infrastructure Tracker – March 2025


Charted Insights: Understanding the Impact of the US Reciprocal Tariff Plan: A Data-Backed Breakdown

By Nimish Maheshwari

  • In early 2025, former US President Donald Trump announced a new “Reciprocal Tariff Plan” as part of his economic strategy to address trade imbalances.
  • The plan involves levying additional tariffs on countries where the US runs a trade deficit, aimed at “equalizing” tariff rates between the US and its trading partners.
  • We analyze how the tariffs across major US trading partners will change post reciprocal tariffs.

Decoding Trump’s Reciprocal Tariffs: Limited Shock for India, Sector Rotation Ahead

By Nimish Maheshwari

  • Trump’s reciprocal tariff plan imposes a 27% duty on Indian goods, sparing pharma and IT but impacting autos, textiles, chemicals, and solar exports.
  • Despite steep headline tariffs, India’s top export sectors, IT services and pharma, remain unaffected, preserving key revenue streams and softening near-term macroeconomic impact.
  • Investors will likely rotate into resilient sectors like pharma and IT while avoiding margin-sensitive names in textiles, chemicals, and auto ancillaries vulnerable to export-led earnings volatility.

Ohayo Japan | Tariffs On, Risk Off

By Mark Chadwick

  • US stocks cratered on Thursday in their worst one-day sell-off since 2020, with the Dow tumbling almost 1,700 points; NKY Futures weaker
  • Mitsubishi Corporation plans to buy back up to ¥1 trillion of its shares, acquiring up to 689 million shares, or 17% of total issued shares
  • An investment company associated with activist investor Yoshiaki Murakami has acquired over 5% of Fuji Media Holdings’ outstanding shares

Junior Copper Miners: An Update After 1Q25

By Nicolas Van Broekhoven

  • Copper prices started the year roaring: +26% YTD. US futures prices outpaced LME prices.
  • Much of the trade was driven by re-allocation of copper inventories to beat potential US tariffs. The  White House yesterday exempted copper from any import tariffs.
  • Copper miners show a mixed bag, our basket of favorites was led by Arras Minerals (ARK V EQUITY) which increased 182% YTD.

No Tariffs on Semiconductors – but Does It Matter?

By Nicolas Baratte

  • Import tariff into the US: Korea 25%, Taiwan 32%. But the White house clarified: no Reciprocal Tariff on semiconductors.  
  • There are other exemption (pharmaceuticals, lumber, certain minerals not available in the US). But then Apple or Nvidia don’t import Semis from Taiwan or Korea. 
  • They import iPhones from China / India or Servers made in Taiwan. Is it a little bug to be fixed? There’s an interesting loophole: 10% tariff on Singapore.  

Japan Morning Connection: Rough Start with US Meltdown but Trump Showing Willingness to Negotiate

By Andrew Jackson

  • Huge losses for tech/AI/banks in the biggest selloff since Covid.
  • Intel gaining after reports it has agreed to a JV with TSMC for their Fab business.
  • Sec. of State Rubio pushing EU leaders to shoulder a higher defence burden; European plays higher.

Hardman & Co Insight: 2024 Pharma Statistics

By Hardman & Co

  • An efficient reporting system has seen all the listed multinational pharmaceutical companies announce results for 2024, which has given us the opportunity to update our industry statistics and drug database.
  • This report provides the first snapshot of global pharmaceutical market growth plus the global and US company rankings for 2024.
  • The year was characterised by 9.2% underlying (ex-COVID-19) growth.

South African Listed Property Review – March 2025

By Garreth Elston

  • March was an extremely busy month for the SA listed property sector with earnings, pre-close, and interim releases coming thick and fast.
  • The SA All Property Index was down -4.12% for the quarter, the FTSE EPRA Nareit Global Index in ZAR was down -1.21%, and in USD down by -1.67%.
  • The best positions remain in property companies as insulated from international macro issues as possible, those with steady cash flows, tenants providing necessary products and/or services, plus low debt levels.

US EV Charging Infrastructure Tracker – March 2025

By Garvit Bhandari

  • Total public EV charging stations (incl. temporary unavailable locations) were 77,514 as of March 31, 2025. Compared to the end of FY24, it is an increase of 3.4%. 
  • Total EV charging ports (including the temporary unavailable ports) were 217,353, up nearly 5.1% compared to the end of 2024 and up 2.0% over February 2025.
  • California has the highest number of active DC Fast ports as of March 2025 at 13,611 (~26% of the total), followed by Texas at 3,347 .

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars